Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.
about
The global programme to eliminate lymphatic filariasis: health impact after 8 yearsA research agenda for helminth diseases of humans: the problem of helminthiasesMulticentre evaluations of two new rapid IgG4 tests (WB rapid and panLF rapid) for detection of lymphatic filariasisElimination and eradication of neglected tropical diseases with mass drug administrations: a survey of expertsA research agenda for helminth diseases of humans: intervention for control and eliminationA research agenda for helminth diseases of humans: towards control and eliminationTropical pulmonary eosinophilia--a reviewAn integrated in vitro imaging platform for characterizing filarial parasite behavior within a multicellular microenvironmentGlobal eradication of lymphatic filariasis: the value of chronic disease control in parasite elimination programmesLymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmissionThe impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New GuineaThe impact of a filariasis control program on Lihir Island, Papua New GuineaEpidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in NigeriaA multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasisReduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New GuineaLongitudinal monitoring of the development of antifilarial antibodies and acquisition of Wuchereria bancrofti in a highly endemic area of HaitiAntibody to the filarial antigen Wb123 reflects reduced transmission and decreased exposure in children born following single mass drug administration (MDA)Identification of Wb123 as an early and specific marker of Wuchereria bancrofti infectionDiagnosis of brugian filariasis by loop-mediated isothermal amplificationEpidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluationImpact of six rounds of mass drug administration on Brugian filariasis and soil-transmitted helminth infections in eastern IndonesiaNo evidence for lymphatic filariasis transmission in big cities affected by conflict related rural-urban migration in Sierra Leone and LiberiaA comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administrationAssessing progress in reducing the at-risk population after 13 years of the global programme to eliminate lymphatic filariasisProgress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial diseaseCessation of mass drug administration for lymphatic filariasis in Zanzibar in 2006: was transmission interrupted?Programmatic Use of Molecular Xenomonitoring at the Level of Evaluation Units to Assess Persistence of Lymphatic Filariasis in Sri LankaXenomonitoring of different filarial nematodes using single and multiplex PCR in mosquitoes from Assiut Governorate, EgyptNeglected patients with a neglected disease? A qualitative study of lymphatic filariasis.Temporal epidemiology of microfilaraemia among migrant workers entering KuwaitDetection of Wuchereria bancrofti L3 larvae in mosquitoes: a reverse transcriptase PCR assay evaluating infection and infectivityThe 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: A half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases.Control of neglected tropical diseases needs a long-term commitmentThe global distribution and transmission limits of lymphatic filariasis: past and present.Has the NTD community neglected evidence-based policy? PLOS NTDs 2013 expert commentary of the viewpoint by Nagpal S, Sinclair D, Garner P.Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration.Population migration: implications for lymphatic filariasis elimination programmes.Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmissionThe argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasisUse of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels.
P2860
Q21092299-B77DFFEB-028B-4D25-8779-024325D959C0Q21144498-EDBD1A7B-57B5-40D5-8F5E-A2867E46B235Q21245927-05AC9D5F-F0D9-40F8-BEF2-F0817420789FQ21562239-BA207BD6-76AD-4084-B66F-E82ED6FE9961Q21562256-AA9F15F8-38CD-42E2-91F8-BCA44C28AE36Q21562257-77784030-54A5-4839-9362-B6493F07A031Q27009456-6A592B35-84C5-4234-B82D-8E0FBE808AC5Q27304737-D833FAE9-5232-438D-A39D-18AAB8E4BDE9Q28473359-D4EF1E51-C1C4-437F-8FAD-8B439C97BC6EQ28474138-A44D1AE0-75A9-4C19-9E51-1459B3EC36D5Q28474163-A90EE8ED-5588-4F90-9D56-C0F4B298CCF0Q28476658-5FE931F0-6328-43CC-8811-C2D33991C6F7Q28477441-A8A028F9-BFFD-46A8-B04B-68FC193FA642Q28478938-8EF6FFA3-EFEE-43ED-ADF5-15AA69BCC55CQ28478979-CB7CF1B4-BA43-407D-9120-EDB84FBC65F6Q28484230-3E3CF91C-5822-4AE5-8355-9A7132809B66Q28484232-734A8320-ABAA-431D-8185-51B31C722813Q28484234-9E844925-34CF-4223-B7D4-41DC0DF2A967Q28484345-C90AF1FD-6B1B-485D-A7F9-57B6A3AFC554Q28485376-255EEF49-7F32-41A6-8530-1FF8A5FAAFBEQ28536914-5935385E-509F-4F38-9FA2-4B97BBAC0FBEQ28539608-FD21A615-136B-4C6F-B5F5-27788CE435A1Q28544914-13C82384-69F3-485F-A0BC-A934BC1FFD55Q28545084-69CF4809-F971-4A8B-8DB1-6630ADC5D842Q28545108-548647EC-C661-439F-8DD7-04C19913D189Q28545122-332BDA68-DB18-4AEE-94B5-398D1CCDDD80Q28552240-B06BE64D-8077-4D8C-B31F-FF7B1327118FQ28650406-11AC5EDF-74AE-4600-8CD3-C0480B9976AFQ33308747-0484487F-C90F-4585-9139-FA38420065B1Q33360876-534AE853-E82F-461E-BCD0-B9B3852E35D2Q33532615-D088F519-D54A-45CE-88AB-7C400C522E9CQ34322310-5AB3BAC8-5BE0-469E-A449-7F2FFDF07473Q34331536-E133243D-0AF3-498A-B6C3-5C261465B67EQ34340088-57431CB9-74B8-4915-AC4D-884667D831D1Q34359108-8227DD82-2E5C-4B8D-B73B-DE6E99752AA6Q34517923-52C57F75-1FC4-484A-BA0F-130A0A936DD6Q34654148-15EF8BFC-64D0-48C5-B8F2-E4195FED5DCEQ34839765-870D2037-E4E4-4B0E-826D-69BC493C0B01Q35017384-22C714B9-A5C5-48A6-89D9-F6DA738007F8Q35019772-87DDEC5B-8253-41A7-B5E6-9C54A4C729B8
P2860
Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Effect of yearly mass drug adm ...... t: a comprehensive assessment.
@en
Effect of yearly mass drug adm ...... t: a comprehensive assessment.
@nl
type
label
Effect of yearly mass drug adm ...... t: a comprehensive assessment.
@en
Effect of yearly mass drug adm ...... t: a comprehensive assessment.
@nl
prefLabel
Effect of yearly mass drug adm ...... t: a comprehensive assessment.
@en
Effect of yearly mass drug adm ...... t: a comprehensive assessment.
@nl
P2093
P50
P1433
P1476
Effect of yearly mass drug adm ...... pt: a comprehensive assessment
@en
P2093
Ehab S Ahmed
Gary J Weil
Hanan Helmy
Maged El Setouhy
William D Shannon
P304
P356
10.1016/S0140-6736(06)68426-2
P407
P577
2006-03-01T00:00:00Z